As a part of US enlargement plans Lumiera Well being Appoints Jacqueline Khayat to Board of Administrators

MONTREAL, Feb. 22, 2022 /CNW Telbec/ – Lumiera Well being Inc. (TSXV: NHP) (the “Firm” or “Lumiera “), an organization specializing within the improvement and commercialization of pure well being merchandise, is happy to announce that Jacqueline Khayat has been appointed to the Board of Administrators of the Firm.

Lumiera Well being Inc. Brand (CNW Group/Lumiera Well being Inc.)

“As beforehand introduced, we’re executing the primary section of our US enlargement and we’re very excited to have Ms. Khayat be a part of the board as we transfer into the following section of our plan. Her expertise launching manufacturers within the US might be an incredible asset to the workforce” mentioned Carlos Ponce, CEO of Lumiera Well being. “Ms. Khayat brings greater than 20 years of mixed expertise in gross sales, enterprise improvement, technique, and M&A within the well being & wellness sector.”

Ms. Khayat’s previous experiences contains management positions at Neptune Wellness Options the place she led the event and launch of a number of of the corporate’s shopper product manufacturers in USA and different markets. All through her profession, Ms. Khayat has additionally held a number of key positions with international life science firms and has expertise main gross sales groups, producing new enterprise alternatives, and M&A. As well as, Ms. Khayat has been concerned in a number of start-up firms as an investor and advisor. She can also be a Board Member of Caisse Populaire St-Martin de Laval and a member of Anges Quebec.

Ms. Khayat holds a bachelor’s diploma in Science with a Diet main from the School of Drugs of Montreal College. She additionally holds a Graduate Diploma in Administration from HEC Montreal and an Govt MBA from the John Molson College of Enterprise.

The Firm’s Board has granted an incentive inventory choices to Mrs. Khayat, entitling the acquisition of an mixture 300,000 widespread shares at a per share value of $0.05 for a interval of 10 years.

About Lumiera Well being

Lumiera specializes within the improvement and commercialization of shopper merchandise for the pure well being trade. The Firm sells natural tonics and pure dietary supplements by means of its Holizen Laboratories division, with a various portfolio together with a line of progressive sleep aids. The Firm can also be commercializing a novel topical product line performing on the endocannabinoid system, with out the usage of hashish, that gives an progressive resolution for power ache and irritation. A pioneer within the pure well being innovation area, the Lumiera model is rooted within the core values of science, nature and compassion. Our objective is to make individuals’s lives higher by growing pure well being and wellness merchandise which can be efficient, protected and reliable.

For extra data go to: www.lumiera.ca.

Neither the TSX Enterprise Change nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Change) accepts duty for the adequacy or accuracy of this launch.

Ahead-looking data

Sure statements contained on this press launch represent “forward-looking data” as such time period is outlined in relevant Canadian securities laws. The phrases “might”, “would”, “may”, “ought to”, “potential”, “will”, “search”, “intend”, “plan”, “anticipate”, “consider”, “estimate”, “count on” and related expressions point out such “forward-looking data” as they relate to Lumiera. All statements aside from statements of historic reality could also be forward-looking data. Such statements mirror Lumiera’ present views and intentions with respect to future occasions, and present data obtainable to Lumiera, and are topic to sure dangers, uncertainties and assumptions. Such dangers and uncertainties embrace, amongst others, the danger elements included in Lumiera’ annual administration’s dialogue and evaluation for the yr ended November 30, 2020, which is obtainable beneath the issuer’s SEDAR profile at www.sedar.com. Materials elements or assumptions had been utilized in offering forward-looking data. Many elements may trigger the precise outcomes, efficiency or achievements which may be expressed or implied by such forward-looking data to range from these described herein ought to a number of of those dangers or uncertainties materialize. Ought to any issue have an effect on Lumiera in an sudden method, or ought to assumptions underlying the forward-looking data show incorrect, the precise outcomes or occasions might differ materially from the outcomes or occasions predicted. Any such forward-looking data is expressly certified in its entirety by this cautionary assertion. Furthermore, Lumiera doesn’t assume duty for the accuracy or completeness of such forward-looking data. The forward-looking data included on this press launch is made as of the date of this press launch and Lumiera undertakes no obligation to publicly replace or revise any forward-looking data, aside from as required by relevant legislation.

Associated Hyperlinks: www.lumiera.ca

SOURCE Lumiera Well being Inc.

Cision

Cision

View unique content material to obtain multimedia: http://www.newswire.ca/en/releases/archive/February2022/22/c9450.html

Previous post Food regimen Ideas: 5 Causes Why It is Extremely Harmful to Skip Meals
Next post Zelira Therapeutics Ltd to streamline pipeline by buying pharmaceutical distributor Well being Home Worldwide Restricted